创新的重要性。批评者声称基因专利可能导致非常广泛的垄断并抑制进一步的创新。欧洲专利制度提供了有效的法律手段来解决这些问题。
The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.
作者信息
Rutz Berthold, Yeats Siobhán
机构信息
European Patent Office, Munich, Germany.
出版信息
EMBO Rep. 2004 Feb;5(2):119-23. doi: 10.1038/sj.embor.7400068.
Abstract
Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues
摘要
批评者声称，基因专利可能会导致非常广泛的垄断，并抑制进一步的创新。欧洲专利制度提供了有效的法律手段来解决这些问题。
相似文献
1
The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.创新的重要性。批评者声称基因专利可能导致非常广泛的垄断并抑制进一步的创新。欧洲专利制度提供了有效的法律手段来解决这些问题。
EMBO Rep. 2004 Feb;5(2):119-23. doi: 10.1038/sj.embor.7400068.
2
Collaborative research presents special problems for patent seekers.合作研究给专利申请者带来了特殊问题。
Nat Biotechnol. 2004 Jul;22(7):901-2. doi: 10.1038/nbt0704-901.
3
Patenting and ethics--a dubious connection.专利与伦理——一种可疑的联系。
J Pat Trademark Off Soc. 2003 Jan;85(1):31-47.
4
Much ado about gene patents: the role of foreseeability.基因专利引发的诸多争议：可预测性的作用。
Seton Hall Law Rev. 2004;34(2):711-45.
5
"Obvious to try": a proper patentability standard in the pharmaceutical arts?“显而易见可尝试”：制药领域合适的可专利性标准？
Fordham Law Rev. 2008 Apr;76(5):2625-68.
6
Research tool patents: tips for facing a "pay up now or litigate" ultimatum.研究工具专利：应对“立即付款或诉讼”最后通牒的小贴士。
Nat Biotechnol. 2001 Nov;19(11):1075-7. doi: 10.1038/nbt1101-1075.
7
Progress on patents, but more action is needed.
Nature. 1997 Jul 24;388(6640):309. doi: 10.1038/40918.
8
[Biotechnological invention patents: a legal-economic analysis].[生物技术发明专利：法律经济分析]
Rev Derecho Genoma Hum. 1998 Jan-Jun(8):159-86.
9
Intellectual property and biotechnology: the U.S. internal experience--Part II.知识产权与生物技术：美国国内经验——第二部分
Kennedy Inst Ethics J. 2006 Jun;16(2):105-28. doi: 10.1353/ken.2006.0007.
10
One patent a day keeps the doctor away? Patenting human genetic information and health care.
Eur J Health Law. 2000 Sep;7(3):229-64. doi: 10.1163/15718090020523188.
引用本文的文献
1
Trends in genetic patent applications: the commercialization of academic intellectual property.基因专利申请趋势：学术知识产权的商业化
Eur J Hum Genet. 2014 Oct;22(10):1155-9. doi: 10.1038/ejhg.2013.305. Epub 2014 Jan 22.
2
The economics of biotechnology.
J Biosci. 2005 Mar;30(2):151-4. doi: 10.1007/BF02703694.
本文引用的文献
1
Are DNA patents bad for medicine?DNA专利对医学有害吗？
Health Policy. 2003 Aug;65(2):181-97. doi: 10.1016/s0168-8510(02)00206-3.
2
Impact of gene patenting on R&D and commerce.基因专利对研发与商业的影响。
Nat Biotechnol. 2003 Jul;21(7):729-31; author reply 731. doi: 10.1038/nbt0703-729.
3
SARS genome patent: symptom or disease?非典病毒基因组专利：症状还是疾病？
Lancet. 2003 Jun 14;361(9374):2002-3. doi: 10.1016/S0140-6736(03)13674-4.
4
The economics of human gene patents.人类基因专利的经济学
Acad Med. 2002 Dec;77(12 Pt 2):1348-67. doi: 10.1097/00001888-200212001-00006.
5
Patents and public health. European institutions are challenging Myriad Genetics's patent monopoly on the brca1 gene.专利与公共卫生。欧洲机构正在挑战Myriad Genetics公司对BRCA1基因的专利垄断。
EMBO Rep. 2002 Dec;3(12):1120-2. doi: 10.1093/embo-reports/kvf251.
6
Shares in the human genome--the future of patenting DNA.人类基因组的股份——DNA专利的未来。
Nat Biotechnol. 2002 Dec;20(12):1185-8. doi: 10.1038/nbt1202-1185.
7
Genes and patent policy: rethinking intellectual property rights.基因与专利政策：对知识产权的重新思考
Nat Rev Genet. 2002 Oct;3(10):803-8. doi: 10.1038/nrg909.
8
Gene patents and the standard of care.基因专利与医疗标准。
CMAJ. 2002 Aug 6;167(3):256-7.
9
Diagnostic testing fails the test.诊断测试未通过测试。
Nature. 2002 Feb 7;415(6872):577-9. doi: 10.1038/415577a.
10
Intellectual property. Patents, secrecy, and DNA.知识产权。专利、保密与DNA。
Science. 2001 Jul 13;293(5528):217. doi: 10.1126/science.1058032.
Zotero 插件